Knowridge2d
A new wearable treatment for Parkinson’s motor fluctuations
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
Hosted on MSN5mon
How a ‘pacemaker’ for the brain fights off Parkinson’s
He found that his right hand was cupping, while his balance and alignment started to seem off. Over time, he developed a common Parkinson ... to seven days over a period of two months, the ...
Pharm Exec2d
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
pharmaphorum2y
AbbVie files continuous Parkinson's therapy ABBV-951 in US
the period where muscle symptoms associated with Parkinson's are controlled without involuntary, uncontrolled movements – at 12 weeks. There was also a reduction in "off" hours, when Parkinson's ...
Morningstar6d
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
The primary efficacy endpoint was the mean change in total daily OFF time assessed from baseline to the end of the 12-week treatment period based ... for adults with Parkinson’s disease who ...
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...